BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38301513)

  • 1. Prediction model of radiotherapy outcome for Ocular Adnexal Lymphoma using informative features selected by chemometric algorithms.
    Zhou M; Wang J; Shi J; Zhai G; Zhou X; Ye L; Li L; Hu M; Zhou Y
    Comput Biol Med; 2024 Mar; 170():108067. PubMed ID: 38301513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular adnexal follicular lymphoma: a multicenter international study.
    Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
    JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-Based Radiomics Nomogram for Preoperative Differentiation Between Ocular Adnexal Lymphoma and Idiopathic Orbital Inflammation.
    Yang L; Zhang H; Xie X; Jiang S; Zhang H; Cao X; Hou Y; He X; Wang J; Zhang T; Zhao F
    J Magn Reson Imaging; 2023 May; 57(5):1594-1604. PubMed ID: 36053805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.
    Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Stein H
    Graefes Arch Clin Exp Ophthalmol; 2004 Feb; 242(2):130-145. PubMed ID: 14685876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular adnexal lymphomas: An eye care service experience in Turkey.
    Kiziltas B; Baskan C; Duman R; Dal MS
    Niger J Clin Pract; 2018 Jun; 21(6):711-715. PubMed ID: 29888716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.
    Auw-Haedrich C; Coupland SE; Kapp A; Schmitt-Gräff A; Buchen R; Witschel H
    Br J Ophthalmol; 2001 Jan; 85(1):63-9. PubMed ID: 11133714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics.
    Husain A; Roberts D; Pro B; McLaughlin P; Esmaeli B
    Cancer; 2007 Aug; 110(4):809-15. PubMed ID: 17594698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease.
    Valenzuela AA; Allen C; Grimes D; Wong D; Sullivan TJ
    Ophthalmology; 2006 Dec; 113(12):2331-7. PubMed ID: 16996604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Adnexal Lymphomas: Single-Center Experience.
    Özkan MC; Palamar M; Tombuloğlu M; Hekimgil M; Özsan N; Saydam G; Şahin F
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S158-60. PubMed ID: 26297270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular adnexal lymphoma: validation of American Joint Committee on Cancer seventh edition staging guidelines.
    Sniegowski MC; Roberts D; Bakhoum M; Mc Laughlin P; Yin VT; Turturro F; Esmaeli B
    Br J Ophthalmol; 2014 Sep; 98(9):1255-60. PubMed ID: 24759874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular adnexal lymphoma: A single-institution retrospective study.
    Fernández CA; Henry RK; Shields CL; Bilyk JR; Lally SE; Eagle RC; Milman T
    Saudi J Ophthalmol; 2021; 35(3):230-238. PubMed ID: 35601857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ten year experience with ocular lymphomas and ocular adnexae lymphomas].
    Caballero-Caballero R; Hernández-Rivera EG; López-Karpovitch JX
    Gac Med Mex; 2006; 142(5):393-7. PubMed ID: 17128819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
    Pinnix CC; Dabaja BS; Milgrom SA; Smith GL; Abou Z; Nastoupil L; Romaguera J; Turturro F; Fowler N; Fayad L; Westin J; Neelapu S; Fanale MA; Rodriguez MA; Hagemeister F; Lee HJ; Oki Y; Wang M; Samaniego F; Chi L; Esmaeli B
    Head Neck; 2017 Jun; 39(6):1095-1100. PubMed ID: 28370694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving diagnostic performance of differentiating ocular adnexal lymphoma and idiopathic orbital inflammation using intravoxel incoherent motion diffusion-weighted MRI.
    Jiang H; Wang S; Li Z; Xie L; Wei W; Ma J; Xian J
    Eur J Radiol; 2020 Sep; 130():109191. PubMed ID: 32745898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary malignancies after ocular adnexal lymphoma diagnosis.
    Loya A; Ramachandran V; Ayaz T; Weng CY
    BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A deep learning model combining multimodal radiomics, clinical and imaging features for differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.
    Xie X; Yang L; Zhao F; Wang D; Zhang H; He X; Cao X; Yi H; He X; Hou Y
    Eur Radiol; 2022 Oct; 32(10):6922-6932. PubMed ID: 35674824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017.
    Holm F; Mikkelsen LH; Kamper P; Rasmussen PK; Larsen TS; Sjö LD; Heegaard S
    Br J Ophthalmol; 2021 Jul; 105(7):914-920. PubMed ID: 32732342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.
    Guo J; Liu Z; Shen C; Li Z; Yan F; Tian J; Xian J
    Eur Radiol; 2018 Sep; 28(9):3872-3881. PubMed ID: 29632999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and treatment outcomes of diffuse large B-cell lymphoma involving the eye and ocular adnexa in East Asia.
    Han SH; Kim YD; Jang J; Park JW; Young SM; Woo KI
    Acta Ophthalmol; 2021 Nov; 99(7):773-782. PubMed ID: 33421300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.